by telrheum | May 25, 2024 | IgG4-Related Diseases, Low Complements
Background IgG4-related disease (IgG4-RD) is an autoimmune condition that can affect various organs. Some patients with IgG4-RD have low levels of complement proteins in their blood. This study aimed to compare the characteristics and disease activity of IgG4-RD...
by telrheum | May 19, 2024 | Biologic Therapy, Infections, Lupus, Rheumatoid Arthritis, Rituximab, Vasculitis
The article “Risk of Severe Infections Associated with Immunoglobulin Deficiency Under Rituximab Therapy in Immune Mediated Inflammatory Diseases” by Claire Rempenault and colleagues evaluates the connection between severe infections and immunoglobulin deficiency in...
by telrheum | Apr 21, 2024 | Lupus, Hydroxychloroquine
The study discussed in the article focuses on the prevalence and risk factors associated with retinal toxicity in patients using hydroxychloroquine (HCQ) for over five years, primarily for autoimmune diseases. This medication is generally safe but has been linked to...
by telrheum | Apr 21, 2024 | Lupus, Malignancy
The article titled “Incidence of and Risk Factors for Myelodysplastic Syndromes in Patients with Rheumatologic Diseases” by YoungEun Kim and colleagues focuses on the connection between rheumatologic diseases and myelodysplastic syndromes (MDS), a type of...
by telrheum | Mar 23, 2024 | Autoimmune Diseases, Arthritis Supplements, Gastrointestinal, Lupus, Rheumatoid Arthritis
The gut microbiome, an intricate community of microorganisms residing in our digestive tract, plays a pivotal role in shaping our health and disease states. Recent research has illuminated its significant influence on the immune system, particularly in the context of...
